Acetic Acid

Acetic Acid

SCHEMBL721668

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].O.[Ce+3]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.80
CA4 P22748 3/20 0.54
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.42
FFAR3 O14843 2/20 0.42
THPO P40225 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
ALOX15 P16050 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
FAHD1 Q6P587 1/20 0.39
CES1 P23141 1/20 0.35
ALDH1A1 P00352 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL31454250 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL3683091 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL26101431 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL231131 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL14245773 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL25334487 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL2176610 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL34888 0.95 CA1 (0.89) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL25170206 0.90 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL21848043 0.90 CA1 (0.80) CA1CA4LMNATSHRFFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080767-A Rare earth modified wear-resistant enameled wire insulating paint and preparation method thereof 2026-05-26 CN claimed
CN-122076451-A Modified Ni/CeO2Preparation method and application of catalyst 2026-05-26 CN claimed
EP-4744682-A1 NOVEL CERIUM OXIDE NANOCOMPOSITE WITH ENHANCED BIOSTABILITY AND USE THEREOF Cenyx Biotech Inc. (KR) 2026-05-20 EP claimed
US-12458665-B2 Cerium oxide nanocomposite and use thereof CENYX BIOTECH INC. (KR) 2025-11-04 US claimed
US-20250233182-A1 DURABLE MEMBRANE-ELECTRODE ASSEMBLY WITH HIGH IONIC CONDUCTIVITY AND METHOD OF MANUFACTURING SAME HYUNDAI MOTOR COMPANY (KR) 2025-07-17 US claimed
CN-120114478-A Multimode nano-immunoregulator for rescuing damaged vascular nerve units and preparation method thereof 中国医学科学院肿瘤医院 2025-06-10 CN claimed
CN-119752086-A Highway LED transparent lens mask and preparation method thereof 惠州宗汉博创科技有限公司 2025-04-04 CN claimed
CN-119571370-A Pb-CeO2Composite catalyst, preparation method and application thereof 南京理工大学 2025-03-07 CN claimed
CN-119500108-A Modified manganese-based denitration catalyst and preparation method thereof 国家能源集团科学技术研究院有限公司 2025-02-25 CN claimed
CN-117820088-B Preparation method of m-ethylanisole 万华化学集团股份有限公司 2025-02-18 CN claimed
WO-2007043774-A1 PROCESS FOR PRODUCING CERIUM OXIDE NANOCRYSTALS SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2007-04-19 WO claimed
EP-1711575-A2 DEICER COMPOSITIONS INCLUDING CORROSION INHIBITORS Cargill, Incorporated (US) 2006-10-18 EP claimed
US-20060032147-A1 Method of preparing slurry composition for chemical mechanical polishing SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-02-16 US claimed
US-20050230658-A1 Deicer compositions including corrosion inhibitors CARGILL, INCORPORATED 2005-10-20 US claimed
WO-2005071036-A2 DEICER COMPOSITIONS INCLUDING CORROSION INHIBITORS CARGILL, INCORPORATED (US) 2005-08-04 WO claimed
US-20040126298-A1 Flame made metal oxides EIDGENOSSISCHE TECHNISCHE HOCHSCULE ZURICH (CH) 2004-07-01 US claimed
EP-1378489-A1 Metal oxides prepared by flame spray pyrolysis Eidgenössische Technische Hochschule Zürich (CH) 2004-01-07 EP claimed
US-6579472-B2 Combination of an organometallic salt, an organosilane, and a borate, phosphate, or zinc functional component. THE BOEING COMPANY 2003-06-17 US claimed
US-20030024432-A1 Combination of an organometallic salt, an organosilane, and a borate, phosphate, or zinc functional component. THE BOEING COMPANY 2003-02-06 US claimed
US-5939197-A COATING METAL WITH ORGANOMETALLIC AND ORGANOSILICON COMPOUNDS; COMPLEXING AND BONDING WITH MATRIX RESIN; CATALYTIC HYDROLYSIS USING ACETIC ACID THE BOEING COMPANY (US) 1999-08-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250233182-A1 DURABLE MEMBRANE-ELECTRODE ASSEMBLY WITH HIGH IONIC CONDUCTIVITY AND METHOD OF MANUFACTURING SAME TMEM109, SLC9A1, SLC9A2 CA1 201/4885CA4 716/4885LMNA 892/4885
US-12458665-B2 Cerium oxide nanocomposite and use thereof CD59, CLN6, CERS2 CA1 300/4885CA4 306/4885LMNA 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.